Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The absence of insulin signaling in the heart induces changes in potassium channel expression and ventricular repolarization.

American journal of physiology. Heart and circulatory physiology | 2014

Diabetes mellitus increases the risk for cardiac dysfunction, heart failure, and sudden death. The wide array of neurohumoral changes associated with diabetes pose a challenge to understanding the roles of specific pathways that alter cardiac function. Here, we use a mouse model with cardiomyocyte-restricted deletion of insulin receptors (CIRKO, cardiac-specific insulin receptor knockout) to study the specific effects of impaired cardiac insulin signaling on ventricular repolarization, independent of the generalized metabolic derangements associated with diabetes. Impaired insulin action caused a reduction in mRNA and protein expression of several key K(+) channels that dominate ventricular repolarization. Specifically, components of transient outward K(+) current fast component (Ito,fast; Kv4.2 and KChiP2) were reduced, consistent with a reduction in the amplitude of Ito,fast in isolated left ventricular CIRKO myocytes, compared with littermate controls. The reduction in Ito,fast resulted in ventricular action potential prolongation and prolongation of the QT interval on the surface ECG. These results support the notion that the lack of insulin signaling in the heart is sufficient to cause the repolarization abnormalities described in other animal models of diabetes.

Pubmed ID: 24375641 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: K99-HL-111322
  • Agency: NIDDK NIH HHS, United States
    Id: R01DK092065
  • Agency: NHLBI NIH HHS, United States
    Id: R00 HL111322
  • Agency: NHLBI NIH HHS, United States
    Id: UO1HL087947
  • Agency: NHLBI NIH HHS, United States
    Id: T32-HL-007576
  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL007576

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


KChIP2 potassium channel (antibody)

RRID:AB_10671304

This monoclonal targets KChIP2 potassium channel

View all literature mentions

Kv4.2 potassium channel (antibody)

RRID:AB_10672254

This monoclonal targets Kv4.2 potassium channel

View all literature mentions

Anti-Kv4.2 K+ Channel Antibody (antibody)

RRID:AB_2131945

This monoclonal targets Kv4.2 K+ channel

View all literature mentions